首页 > 最新文献

Medecine tropicale et sante internationale最新文献

英文 中文
[XXVIIth Actualités du Pharo. Alert and response to health crises: the place of information systems. 5-7 October 2022 Marseille, France]. [XXVIIth Actualités du Pharo.卫生危机的预警和应对:信息系统的作用。2022 年 10 月 5-7 日,法国马赛]。
Pub Date : 2023-03-02 eCollection Date: 2023-03-31 DOI: 10.48327/mtsi.v3i1.2023.332
Gispe Organisateur
{"title":"[XXVII<sup>th</sup> Actualités du Pharo. Alert and response to health crises: the place of information systems. 5-7 October 2022 Marseille, France].","authors":"Gispe Organisateur","doi":"10.48327/mtsi.v3i1.2023.332","DOIUrl":"10.48327/mtsi.v3i1.2023.332","url":null,"abstract":"","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-03-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9738605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Characteristics and predictive factors of death in acute coronary syndromes among the elderly: data from the Acute coronary syndrome registry at the Abidjan Heart Institute]. [老年人急性冠状动脉综合征的特征和死亡预测因素:阿比让心脏研究所急性冠状动脉综合征登记数据]。
Pub Date : 2023-02-22 eCollection Date: 2023-03-31 DOI: 10.48327/mtsi.v3i1.2023.269
Hermann Yao, Esther Ehouman, Didier Kouadio, Camille Touré, Elvis Sepih, Isabelle Kouamé, Arnaud Ekou, Roland N'guetta

Introduction-objective: Acute coronary syndromes (ACS) are the leading cause of death among the elderly in sub-Saharan Africa. The aim of this study was to analyze the characteristics of ACS among the elderly at the Abidjan Heart Institute.

Materials and methods: Cross-sectional study from January 1, 2015, to December 31, 2019. All patients aged 18 or more admitted to the Abidjan Heart Institute for ACS were included. These patients were divided into two groups: elderly (≥ 65 years old) and non-elderly (< 65 years old). Clinical data, management and outcomes were compared and analyzed in both groups.

Results: A total of 570 patients were included, of which 137 (24%) were elderly. Sixty percent (60%) of elderly patients presented with ST Segment Elevation Myocardial Infarction (STEMI). Percutaneous coronary intervention (PCI) was less performed among elderly patients (21.1% vs 30.2%, p = 0.039). Heart failure was the most important complication among the elderly group (56.9% vs 44.6%, p = 0.012). In-hospital mortality was 8% among the elderly. Predictive factors for in-hospital mortality were history of hypertension (HR 2.58; CI95% 1.10-6.08) and STEMI presentation (OR 11.60; CI95% 2.70-49.76). PCI was a protective factor for in-hospital mortality (OR 0.14; IC95% 0.03-0.62).

Conclusion: ACS occur with increasing frequency with age. Poor outcomes among the elderly are determined by the clinical presentation and comorbidities. PCI appears to significantly reduce in-hospital mortality.

导言--目的:急性冠状动脉综合征(ACS)是撒哈拉以南非洲地区老年人死亡的主要原因。本研究旨在分析阿比让心脏研究所老年人急性冠状动脉综合征的特征:横断面研究,时间为 2015 年 1 月 1 日至 2019 年 12 月 31 日。研究对象包括阿比让心脏病研究所收治的所有年龄在18岁或18岁以上的ACS患者。这些患者被分为两组:老年组(≥ 65 岁)和非老年组(< 65 岁)。对两组患者的临床数据、管理和结果进行比较和分析:共纳入 570 名患者,其中 137 名(24%)为老年人。60%的老年患者患有ST段抬高型心肌梗死(STEMI)。老年患者接受经皮冠状动脉介入治疗(PCI)的比例较低(21.1% 对 30.2%,P = 0.039)。心力衰竭是老年组患者最主要的并发症(56.9% 对 44.6%,P = 0.012)。老年人的院内死亡率为 8%。院内死亡率的预测因素是高血压病史(HR 2.58;CI95% 1.10-6.08)和 STEMI 表现(OR 11.60;CI95% 2.70-49.76)。PCI是院内死亡率的保护因素(OR 0.14;IC95% 0.03-0.62):结论:随着年龄的增长,发生 ACS 的频率也在增加。结论:随着年龄的增长,急性心肌梗死的发生率也在增加。老年人的不良预后取决于临床表现和合并症。PCI似乎能明显降低院内死亡率。
{"title":"[Characteristics and predictive factors of death in acute coronary syndromes among the elderly: data from the Acute coronary syndrome registry at the Abidjan Heart Institute].","authors":"Hermann Yao, Esther Ehouman, Didier Kouadio, Camille Touré, Elvis Sepih, Isabelle Kouamé, Arnaud Ekou, Roland N'guetta","doi":"10.48327/mtsi.v3i1.2023.269","DOIUrl":"10.48327/mtsi.v3i1.2023.269","url":null,"abstract":"<p><strong>Introduction-objective: </strong>Acute coronary syndromes (ACS) are the leading cause of death among the elderly in sub-Saharan Africa. The aim of this study was to analyze the characteristics of ACS among the elderly at the Abidjan Heart Institute.</p><p><strong>Materials and methods: </strong>Cross-sectional study from January 1, 2015, to December 31, 2019. All patients aged 18 or more admitted to the Abidjan Heart Institute for ACS were included. These patients were divided into two groups: elderly (≥ 65 years old) and non-elderly (< 65 years old). Clinical data, management and outcomes were compared and analyzed in both groups.</p><p><strong>Results: </strong>A total of 570 patients were included, of which 137 (24%) were elderly. Sixty percent (60%) of elderly patients presented with ST Segment Elevation Myocardial Infarction (STEMI). Percutaneous coronary intervention (PCI) was less performed among elderly patients (21.1% vs 30.2%, p = 0.039). Heart failure was the most important complication among the elderly group (56.9% vs 44.6%, p = 0.012). In-hospital mortality was 8% among the elderly. Predictive factors for in-hospital mortality were history of hypertension (HR 2.58; CI95% 1.10-6.08) and STEMI presentation (OR 11.60; CI95% 2.70-49.76). PCI was a protective factor for in-hospital mortality (OR 0.14; IC95% 0.03-0.62).</p><p><strong>Conclusion: </strong>ACS occur with increasing frequency with age. Poor outcomes among the elderly are determined by the clinical presentation and comorbidities. PCI appears to significantly reduce in-hospital mortality.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300662/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9730196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Laveran, the Pasteurian researcher]. [巴斯德研究者Laveran]。
Pub Date : 2023-02-20 eCollection Date: 2023-03-31 DOI: 10.48327/mtsi.v3i1.2023.313
Annick Perrot

At the end of his professorial mandate at the Val de Grâce hospital, Alphonse Laveran, who was Chief Doctor, was appointed to Lille and then Nantes. These assignments however deprived him of a hospital service where he could carry on his research. In 1896, faced with the inflexibility of his military hierarchy, he applied for early retirement; he was then 50 years old. Dr Roux welcomed him to the Pasteur Institute as a honorary department head, where he started a second career as a volunteer. He would spend the following 25 years there, addressing the great protozoology issues. Together with Félix Mesnil, he undertook the study of trypanosomiasis and leishmaniases. In 1907 he was awarded the Nobel Prize in physiology and medicine to honor "his work on the role of protozoa as pandemic vectors". He allocated a large part of his prize money to set up a parasitology laboratory at the Pasteur Institute, where all the discoveries and observations carried out in the colonies would converge. In 1908, he funded the Society of Exotic Pathology. He authored no less than 600 publications where his memorable research is recorded. Despite his somewhat outwardly rigid appearance, the man proved to be of amiable approach thanks to "the simplicity of his manners, his amenity and his great heart".

在Val de Grâce医院教授任期结束时,首席医生Alphonse Laveran被任命为里尔和南特的医生。然而,这些任务剥夺了他可以继续研究的医院服务。1896年,面对军队等级制度的僵化,他申请提前退休;当时他50岁。Roux博士欢迎他作为荣誉系主任来到巴斯德研究所,在那里他开始了第二次志愿者生涯。他将在那里度过接下来的25年,解决重大的原生态学问题。他与费利克斯·梅斯尼尔一起进行了锥虫病和利什曼原虫病的研究。1907年,他被授予诺贝尔生理学和医学奖,以表彰“他在原生动物作为流行病媒介的作用方面所做的工作”。他将奖金的很大一部分用于在巴斯德研究所建立一个寄生虫学实验室,在那里进行的所有发现和观察都将汇集在一起。1908年,他资助了外来病理学学会。他撰写了不少于600份出版物,其中记录了他令人难忘的研究。尽管外表有些刻板,但由于“举止简单、彬彬有礼、心地善良”,这个人的态度很和蔼。
{"title":"[Laveran, the Pasteurian researcher].","authors":"Annick Perrot","doi":"10.48327/mtsi.v3i1.2023.313","DOIUrl":"10.48327/mtsi.v3i1.2023.313","url":null,"abstract":"<p><p>At the end of his professorial mandate at the Val de Grâce hospital, Alphonse Laveran, who was Chief Doctor, was appointed to Lille and then Nantes. These assignments however deprived him of a hospital service where he could carry on his research. In 1896, faced with the inflexibility of his military hierarchy, he applied for early retirement; he was then 50 years old. Dr Roux welcomed him to the Pasteur Institute as a honorary department head, where he started a second career as a volunteer. He would spend the following 25 years there, addressing the great protozoology issues. Together with Félix Mesnil, he undertook the study of trypanosomiasis and leishmaniases. In 1907 he was awarded the Nobel Prize in physiology and medicine to honor \"his work on the role of protozoa as pandemic vectors\". He allocated a large part of his prize money to set up a parasitology laboratory at the Pasteur Institute, where all the discoveries and observations carried out in the colonies would converge. In 1908, he funded the Society of Exotic Pathology. He authored no less than 600 publications where his memorable research is recorded. Despite his somewhat outwardly rigid appearance, the man proved to be of amiable approach thanks to \"the simplicity of his manners, his amenity and his great heart\".</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387291/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9974174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Overview of infectious and non-infectious diseases in French Guiana in 2022]. [2022 年法属圭亚那传染病和非传染病概况]。
Pub Date : 2023-02-17 eCollection Date: 2023-03-31 DOI: 10.48327/mtsi.v3i1.2023.308
Loïc Epelboin, Philippe Abboud, Karim Abdelmoumen, Frédégonde About, Antoine Adenis, Théo Blaise, Romain Blaizot, Timothée Bonifay, Morgane Bourne-Watrin, Mathilde Boutrou, Gabriel Carles, Pierre-Yves Carlier, Jean-François Carod, Luisiane Carvalho, Pierre Couppié, Bertrand De Toffol, François Delon, Magalie Demar, Justin Destoop, Maylis Douine, Jean-Pierre Droz, Narcisse Elenga, Antoine Enfissi, Yves-Kénol Franck, Alexis Fremery, Mélanie Gaillet, Hatem Kallel, Arsène Amadouhé Kpangon, Anne Lavergne, Paul Le Turnier, Lucas Maisonobe, Céline Michaud, Rémi Mutricy, Mathieu Nacher, Richard Naldjinan-Kodbaye, Margot Oberlis, Guillaume Odonne, Lindsay Osei, Jean Pujo, Sébastien Rabier, Brigitte Roman-Laverdure, Cyril Rousseau, Dominique Rousset, Nadia Sabbah, Vincent Sainte-Rose, Roxane Schaub, Karamba Sylla, Marc-Alexandre Tareau, Victor Tertre, Camille Thorey, Véronique Vialette, Gaëlle Walter, Magaly Zappa, Félix Djossou, Nicolas Vignier

Source of many myths, French Guiana represents an exceptional territory due to the richness of its biodiversity and the variety of its communities. The only European territory in Amazonia, surrounded by the Brazilian giant and the little-known Suriname, Ariane 6 rockets are launched from Kourou while 50% of the population lives below the poverty line. This paradoxical situation is a source of health problems specific to this territory, whether they be infectious diseases with unknown germs, intoxications or chronic pathologies.Some infectious diseases such as Q fever, toxoplasmosis, cryptococcosis or HIV infection are in common with temperate countries, but present specificities leading to sometimes different management and medical reasoning. In addition to these pathologies, many tropical diseases are present in an endemic and / or epidemic mode such as malaria, leishmaniasis, Chagas disease, histoplasmosis or dengue. Besides, Amazonian dermatology is extremely varied, ranging from rare but serious pathologies (Buruli ulcer, leprosy) to others which are frequent and benign such as agouti lice (mites of the family Trombiculidae) or papillonitis. Envenomations by wild fauna are not rare, and deserve an appropriate management of the incriminated taxon. Obstetrical, cardiovascular and metabolic cosmopolitan pathologies sometimes take on a particular dimension in French Guiana that must be taken into account in the management of patients. Finally, different types of intoxication are to be known by practitioners, especially due to heavy metals.European-level resources offer diagnostic and therapeutic possibilities that do not exist in the surrounding countries and regions, thus allowing the management of diseases that are not well known elsewhere.Thanks to these same European-level resources, research in Guyana occupies a key place within the Amazon region, despite a smaller population than in the surrounding countries. Thus, certain pathologies such as histoplasmosis of the immunocompromised patient, Amazonian toxoplasmosis or Q fever are hardly described in neighboring countries, probably due to under-diagnosis linked to more limited resources. French Guiana plays a leading role in the study of these diseases.The objective of this overview is to guide health care providers coming to or practicing in French Guiana in their daily practice, but also practitioners taking care of people returning from French Guiana.

法属圭亚那是许多神话的发源地,因其丰富的生物多样性和多样的社区而成为一块独特的土地。法属圭亚那是亚马孙地区唯一的欧洲领土,周围环绕着巴西巨人和鲜为人知的苏里南,阿丽亚娜6号火箭从库鲁发射升空,而50%的人口生活在贫困线以下。这种自相矛盾的情况是该地区特有的健康问题的根源,无论是带有未知病菌的传染病、中毒还是慢性病。一些传染病如 Q 热、弓形虫病、隐球菌病或艾滋病毒感染与温带国家相同,但具有特殊性,导致有时需要不同的管理和医学推理。除这些病症外,许多热带疾病也以地方病和/或流行病的形式出现,如疟疾、利什曼病、南美锥虫病、组织胞浆菌病或登革热。此外,亚马逊地区的皮肤病种类繁多,既有罕见的严重病症(布鲁里溃疡、麻风病),也有常见的良性病症,如疣虱(螨科螨虫)或乳头瘤病毒。由野生动物引起的传染病并不罕见,因此需要对被传染的类群进行适当的管理。在法属圭亚那,产科、心血管和新陈代谢方面的世界性病症有时具有特殊性,在治疗病人时必须加以考虑。欧洲一级的资源提供了周边国家和地区所不具备的诊断和治疗可能性,因此可以治疗在其他地方并不常见的疾病。因此,某些病症,如免疫力低下患者的组织胞浆菌病、亚马逊弓形虫病或 Q 热在邻国几乎没有描述,这可能是由于资源有限导致诊断不足造成的。法属圭亚那在这些疾病的研究中发挥着主导作用。本概述旨在为前来法属圭亚那或在法属圭亚那执业的医疗服务提供者提供日常实践指导,同时也为照顾从法属圭亚那回国人员的从业人员提供指导。
{"title":"[Overview of infectious and non-infectious diseases in French Guiana in 2022].","authors":"Loïc Epelboin, Philippe Abboud, Karim Abdelmoumen, Frédégonde About, Antoine Adenis, Théo Blaise, Romain Blaizot, Timothée Bonifay, Morgane Bourne-Watrin, Mathilde Boutrou, Gabriel Carles, Pierre-Yves Carlier, Jean-François Carod, Luisiane Carvalho, Pierre Couppié, Bertrand De Toffol, François Delon, Magalie Demar, Justin Destoop, Maylis Douine, Jean-Pierre Droz, Narcisse Elenga, Antoine Enfissi, Yves-Kénol Franck, Alexis Fremery, Mélanie Gaillet, Hatem Kallel, Arsène Amadouhé Kpangon, Anne Lavergne, Paul Le Turnier, Lucas Maisonobe, Céline Michaud, Rémi Mutricy, Mathieu Nacher, Richard Naldjinan-Kodbaye, Margot Oberlis, Guillaume Odonne, Lindsay Osei, Jean Pujo, Sébastien Rabier, Brigitte Roman-Laverdure, Cyril Rousseau, Dominique Rousset, Nadia Sabbah, Vincent Sainte-Rose, Roxane Schaub, Karamba Sylla, Marc-Alexandre Tareau, Victor Tertre, Camille Thorey, Véronique Vialette, Gaëlle Walter, Magaly Zappa, Félix Djossou, Nicolas Vignier","doi":"10.48327/mtsi.v3i1.2023.308","DOIUrl":"10.48327/mtsi.v3i1.2023.308","url":null,"abstract":"<p><p>Source of many myths, French Guiana represents an exceptional territory due to the richness of its biodiversity and the variety of its communities. The only European territory in Amazonia, surrounded by the Brazilian giant and the little-known Suriname, Ariane 6 rockets are launched from Kourou while 50% of the population lives below the poverty line. This paradoxical situation is a source of health problems specific to this territory, whether they be infectious diseases with unknown germs, intoxications or chronic pathologies.Some infectious diseases such as Q fever, toxoplasmosis, cryptococcosis or HIV infection are in common with temperate countries, but present specificities leading to sometimes different management and medical reasoning. In addition to these pathologies, many tropical diseases are present in an endemic and / or epidemic mode such as malaria, leishmaniasis, Chagas disease, histoplasmosis or dengue. Besides, Amazonian dermatology is extremely varied, ranging from rare but serious pathologies (Buruli ulcer, leprosy) to others which are frequent and benign such as agouti lice (mites of the family Trombiculidae) or papillonitis. Envenomations by wild fauna are not rare, and deserve an appropriate management of the incriminated taxon. Obstetrical, cardiovascular and metabolic cosmopolitan pathologies sometimes take on a particular dimension in French Guiana that must be taken into account in the management of patients. Finally, different types of intoxication are to be known by practitioners, especially due to heavy metals.European-level resources offer diagnostic and therapeutic possibilities that do not exist in the surrounding countries and regions, thus allowing the management of diseases that are not well known elsewhere.Thanks to these same European-level resources, research in Guyana occupies a key place within the Amazon region, despite a smaller population than in the surrounding countries. Thus, certain pathologies such as histoplasmosis of the immunocompromised patient, Amazonian toxoplasmosis or Q fever are hardly described in neighboring countries, probably due to under-diagnosis linked to more limited resources. French Guiana plays a leading role in the study of these diseases.The objective of this overview is to guide health care providers coming to or practicing in French Guiana in their daily practice, but also practitioners taking care of people returning from French Guiana.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300792/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10109665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Mayotte, a malaria-free island at last?] [马约特岛,终于无疟疾了? ]
Pub Date : 2023-02-15 eCollection Date: 2023-03-31 DOI: 10.48327/mtsi.v3i1.2023.289
Jean-François Lepère, Louis Collet, Ambdoul-Bar Idaroussi, Bruno Pradines

Mayotte is a French overseas department and one of the 4 islands of the Comoros archipelago in the Indian Ocean, located between Madagascar and the eastern coast of Africa. Malaria, mainly by Plasmodium falciparum, is endemic to the archipelago and remained a major public health problem until recent years. To control and then eliminate the disease, major strategies have been established in Mayotte since 2001. Preventive measures, diagnostic testing, treatment and disease surveillance were introduced or improved.From 2002 to 2021, 4819 autochthonous cases were reported in Mayotte where the annual incidence decreased from 10.3 per 1,000 population in 2002 (1649 cases) to less than 0.01 per 1,000 population in 2020 (2 cases). The incidence has been below 1 per 1,000 population since 2009. In 2013, WHO classified Mayotte as a territory in malaria elimination phase. In 2021, no locally acquired malaria cases were reported on the island. During this period 2002-2021, 1898 imported cases were observed. They mainly came from the Union of Comoros (85.8%), Madagascar (8.6%) and sub-Saharan Africa (5,6%). Since 2017, the annual number of locally acquired cases was less than 10 and decreased steadily (9 cases in 2017, 5 in 2018, 4 in 2019 and 2 in 2020). The distribution of these rare locally acquired cases both in time and space suggests that they were introduced and not indigenous cases. A study of the genotypic profile of the plasmodial strains of these cases observed from 2017 to 2020 (17 cases analysed out of 20 diagnosed) confirms that these were certainly introduced cases related to imported cases from the neighboring Comoros.Malaria indigenous transmission seems to be eliminated in Mayotte, but the island remains under threat of reintroduction via cases imported from neighbouring countries. It is time to develop a local plan to prevent reintroduction and to implement a proactive policy of regional cooperation in the fight against malaria.

马约特岛是法国的一个海外省,也是印度洋科摩罗群岛的四个岛屿之一,位于马达加斯加和非洲东海岸之间。疟疾主要由恶性疟原虫引起,是该群岛的地方病,直到近年来仍是一个主要的公共卫生问题。自 2001 年以来,马约特岛制定了多项重大战略,以控制和消除疟疾。从 2002 年到 2021 年,马约特岛共报告了 4819 例本地病例,年发病率从 2002 年的每千人 10.3 例(1649 例)下降到 2020 年的每千人不到 0.01 例(2 例)。自 2009 年以来,发病率一直低于 1‰。2013 年,世卫组织将马约特岛列为处于消灭疟疾阶段的领土。2021 年,该岛没有本地感染疟疾病例的报告。2002-2021 年期间,共发现 1898 例输入病例。这些病例主要来自科摩罗联盟(85.8%)、马达加斯加(8.6%)和撒哈拉以南非洲(5.6%)。自 2017 年以来,每年从本地感染的病例数不足 10 例,且持续减少(2017 年 9 例,2018 年 5 例,2019 年 4 例,2020 年 2 例)。这些罕见的本地感染病例在时间和空间上的分布表明,它们是外来病例而非本地病例。对 2017 年至 2020 年期间观察到的这些病例(20 例诊断病例中分析了 17 例)的质粒菌株基因型的研究证实,这些病例肯定是与邻国科摩罗的输入病例有关的传入病例。现在应该制定一项地方计划,防止疟疾的再次传播,并在防治疟疾的斗争中实施积极的区域合作政策。
{"title":"[Mayotte, a malaria-free island at last?]","authors":"Jean-François Lepère, Louis Collet, Ambdoul-Bar Idaroussi, Bruno Pradines","doi":"10.48327/mtsi.v3i1.2023.289","DOIUrl":"10.48327/mtsi.v3i1.2023.289","url":null,"abstract":"<p><p>Mayotte is a French overseas department and one of the 4 islands of the Comoros archipelago in the Indian Ocean, located between Madagascar and the eastern coast of Africa. Malaria, mainly by <i>Plasmodium falciparum</i>, is endemic to the archipelago and remained a major public health problem until recent years. To control and then eliminate the disease, major strategies have been established in Mayotte since 2001. Preventive measures, diagnostic testing, treatment and disease surveillance were introduced or improved.From 2002 to 2021, 4819 autochthonous cases were reported in Mayotte where the annual incidence decreased from 10.3 per 1,000 population in 2002 (1649 cases) to less than 0.01 per 1,000 population in 2020 (2 cases). The incidence has been below 1 per 1,000 population since 2009. In 2013, WHO classified Mayotte as a territory in malaria elimination phase. In 2021, no locally acquired malaria cases were reported on the island. During this period 2002-2021, 1898 imported cases were observed. They mainly came from the Union of Comoros (85.8%), Madagascar (8.6%) and sub-Saharan Africa (5,6%). Since 2017, the annual number of locally acquired cases was less than 10 and decreased steadily (9 cases in 2017, 5 in 2018, 4 in 2019 and 2 in 2020). The distribution of these rare locally acquired cases both in time and space suggests that they were introduced and not indigenous cases. A study of the genotypic profile of the plasmodial strains of these cases observed from 2017 to 2020 (17 cases analysed out of 20 diagnosed) confirms that these were certainly introduced cases related to imported cases from the neighboring Comoros.Malaria indigenous transmission seems to be eliminated in Mayotte, but the island remains under threat of reintroduction via cases imported from neighbouring countries. It is time to develop a local plan to prevent reintroduction and to implement a proactive policy of regional cooperation in the fight against malaria.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-02-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300655/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9738604","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Principaux facteurs expliquant l'hésitation vaccinale contre la Covid-19 en Tanzanie]. [坦桑尼亚不愿意接种 Covid-19 疫苗的主要原因]。
Pub Date : 2023-01-17 eCollection Date: 2023-03-31 DOI: 10.48327/mtsi.v3i1.2023.307
Mohamed Yunus Rafiq, Ibrahim Simiyu, Hannah Wheatley, Bourema Sissoko, Zachary Enumah, Kheri Tungeraza, Brian J Hall

WHO defines vaccine hesitancy as delay in acceptance or refusal of vaccines despite the availability of vaccine services. It is a complex phenomenon that varies through time, place and vaccines. In this comment, we highlight the context-specific variation of Covid-19 vaccine hesitancy in Tanzania. We suggest Covid-19 hesitancy in Tanzania is influenced with high burden of infectious disease, poor testing capabilities and demographic characteristics.

世卫组织将 "疫苗犹豫不决 "定义为在可获得疫苗服务的情况下仍迟迟不接受或拒绝接受疫苗。这是一种因时间、地点和疫苗而异的复杂现象。在本评论中,我们强调了坦桑尼亚 Covid-19 疫苗犹豫不决的具体情况差异。我们认为,坦桑尼亚的 Covid-19 疫苗迟疑受传染病负担重、检测能力差和人口特征的影响。
{"title":"[Principaux facteurs expliquant l'hésitation vaccinale contre la Covid-19 en Tanzanie].","authors":"Mohamed Yunus Rafiq, Ibrahim Simiyu, Hannah Wheatley, Bourema Sissoko, Zachary Enumah, Kheri Tungeraza, Brian J Hall","doi":"10.48327/mtsi.v3i1.2023.307","DOIUrl":"10.48327/mtsi.v3i1.2023.307","url":null,"abstract":"<p><p>WHO defines vaccine hesitancy as delay in acceptance or refusal of vaccines despite the availability of vaccine services. It is a complex phenomenon that varies through time, place and vaccines. In this comment, we highlight the context-specific variation of Covid-19 vaccine hesitancy in Tanzania. We suggest Covid-19 hesitancy in Tanzania is influenced with high burden of infectious disease, poor testing capabilities and demographic characteristics.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"3 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300656/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9730195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[The dark side of skin lightening]. [皮肤变亮的黑暗面]。
Pub Date : 2022-12-31 DOI: 10.48327/mtsi.v2i4.2022.264
Dorian Cellarier, Alisson Adet, Mathilde Barré
{"title":"[The dark side of skin lightening].","authors":"Dorian Cellarier,&nbsp;Alisson Adet,&nbsp;Mathilde Barré","doi":"10.48327/mtsi.v2i4.2022.264","DOIUrl":"https://doi.org/10.48327/mtsi.v2i4.2022.264","url":null,"abstract":"","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940274/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10765182","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[10 years of the French Muskoka Fund. Impact & future prospects]. [10年的法国马斯科卡基金。影响和未来前景]。
Pub Date : 2022-12-31 DOI: 10.48327/mtsi.v2i4.2022.286
Fleur Vernat

Created at the 2010 G8, the French Muskoka Fund represents France's commitment to maternal and child health. This innovative coordination mechanism between four UN agencies (WHO, UN-Women, UNICEF and UNFPA) has helped improving the health and well-being of mothers, newborns, children, teenagers and young people in 9 countries of Western and Central Africa (Benin, Burkina Faso, Chad, Côte d'Ivoire, Guinea, Mali, Niger, Senegal, and Togo) for the past 11 years. This rare longevity can be explained by its innovative governance structure, its ability to adapt to the local context, its capacity to leverage through high-impact interventions, and its impact on the ground. As the French Muskoka Fund has been renewed for another five years by France in 2021, reflection has been launched to further enhance the catalytic effect of this effective and promising initiative.

法国马斯科卡基金是在2010年八国集团会议上设立的,代表了法国对孕产妇和儿童健康的承诺。四个联合国机构(世卫组织、妇女署、儿童基金会和人口基金)之间的这一创新协调机制在过去11年中帮助改善了西非和中非9个国家(贝宁、布基纳法索、乍得、Côte科特迪瓦、几内亚、马里、尼日尔、塞内加尔和多哥)的母亲、新生儿、儿童、青少年和年轻人的健康和福祉。这种罕见的长寿可以用其创新的治理结构、适应当地环境的能力、通过高影响力干预措施发挥杠杆作用的能力以及对实地的影响来解释。随着法国于2021年将法国马斯科卡基金再延长五年,人们开始反思,以进一步增强这一有效而有希望的倡议的催化作用。
{"title":"[10 years of the French Muskoka Fund. Impact & future prospects].","authors":"Fleur Vernat","doi":"10.48327/mtsi.v2i4.2022.286","DOIUrl":"https://doi.org/10.48327/mtsi.v2i4.2022.286","url":null,"abstract":"<p><p>Created at the 2010 G8, the French Muskoka Fund represents France's commitment to maternal and child health. This innovative coordination mechanism between four UN agencies (WHO, UN-Women, UNICEF and UNFPA) has helped improving the health and well-being of mothers, newborns, children, teenagers and young people in 9 countries of Western and Central Africa (Benin, Burkina Faso, Chad, Côte d'Ivoire, Guinea, Mali, Niger, Senegal, and Togo) for the past 11 years. This rare longevity can be explained by its innovative governance structure, its ability to adapt to the local context, its capacity to leverage through high-impact interventions, and its impact on the ground. As the French Muskoka Fund has been renewed for another five years by France in 2021, reflection has been launched to further enhance the catalytic effect of this effective and promising initiative.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940273/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10765181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali]. [马里巴马科G点大学教学医院感染性和热带病科1例hiv阴性肺结核患者的神经脑膜隐球菌病]。
Pub Date : 2022-12-31 DOI: 10.48327/mtsi.v2i4.2022.282
Ouo-Ouo Loua, Amavi Essénam Alle Akakpo, Dramane Ouedraogo, Yacouba Cissoko, Mariam Soumaré, Issa Konaté, Sounkalo Dao

Neuromeningeal cryptococcosis and pulmonary tuberculosis are respectively serious mycotic and bacterial infections occurring in a subject regardless of its HIV serological status. We report here a case of neuromeningeal cryptococcosis associated with pulmonary tuberculosis and malnutrition in an HIV-seronegative patient with a CD4 count of 750/mm3, to highlight some particularities opposed to certain literatures. This is an 18-year-old patient, housewife, from Bamako, admitted in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako on March 13, 2022 for fever and impaired consciousness. Her symptomatology appears to have gradually set in over a month, preceded by headache resistant to paracetamol, jet vomiting and irregular dry cough, initially treated with ceftriaxone, artesunate and paracetamol for confirmed malaria and suspicion of bacterial meningitis before admission. In whom no known medical-surgical history, no use of topical corticosteroids, no immunosuppressive therapy, no alcohol or tobacco, and no immunosuppressive pathology was found. The diagnoses of neuromeningeal cryptococcosis, pulmonary tuberculosis and undernutrition were retained in view of clinical and microbiological arguments. Diabetes, sickle cell disease, viral hepatitis B and C, kidney failure and cancer, which are immunosuppressive pathologies, were not found. She was successfully treated with first-line oral antituberculous drugs and fluconazole infusion. Three interests are drawn from this clinical case: neuromeningeal cryptococcosis is not only the prerogative of HIV-positive subjects, a high CD4 count does not always mean immunocompetence and fluconazole is an effective therapeutic alternative for neuromeningeal cryptococcosis.

神经脑膜隐球菌病和肺结核分别是严重的真菌和细菌感染,发生在一个对象,无论其HIV血清学状态。我们在此报告一例与肺结核和营养不良相关的神经脑膜隐球菌病,患者为hiv血清阴性,CD4计数为750/mm3,以强调与某些文献相反的一些特殊性。这是一名来自巴马科的18岁患者,家庭主妇,于2022年3月13日因发烧和意识受损入住巴马科G点大学教学医院传染病和热带病科。她的症状似乎在一个多月的时间里逐渐出现,之前出现对扑热息痛有抗药性的头痛、喷射式呕吐和不规则干咳,入院前因确诊疟疾和怀疑细菌性脑膜炎,最初使用头孢曲松、青蒿琥酯和扑热息痛治疗。他们没有已知的内科手术史,没有使用局部皮质类固醇,没有免疫抑制治疗,没有酒精或烟草,也没有发现免疫抑制病理。神经膜隐球菌病、肺结核和营养不良的诊断保留,考虑到临床和微生物的争论。没有发现糖尿病、镰状细胞病、病毒性乙型和丙型肝炎、肾衰竭和癌症等免疫抑制疾病。经一线口服抗结核药物及氟康唑输注治疗成功。从这个临床病例中得出了三个兴趣:神经脊膜隐球菌病不仅仅是hiv阳性受试者的特权,高CD4计数并不总是意味着免疫能力,氟康唑是神经脊膜隐球菌病的有效治疗选择。
{"title":"[Neuromeningeal cryptococcosis in an HIV-negative patient with pulmonary tuberculosis in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako, Mali].","authors":"Ouo-Ouo Loua,&nbsp;Amavi Essénam Alle Akakpo,&nbsp;Dramane Ouedraogo,&nbsp;Yacouba Cissoko,&nbsp;Mariam Soumaré,&nbsp;Issa Konaté,&nbsp;Sounkalo Dao","doi":"10.48327/mtsi.v2i4.2022.282","DOIUrl":"https://doi.org/10.48327/mtsi.v2i4.2022.282","url":null,"abstract":"<p><p>Neuromeningeal cryptococcosis and pulmonary tuberculosis are respectively serious mycotic and bacterial infections occurring in a subject regardless of its HIV serological status. We report here a case of neuromeningeal cryptococcosis associated with pulmonary tuberculosis and malnutrition in an HIV-seronegative patient with a CD4 count of 750/mm<sup>3</sup>, to highlight some particularities opposed to certain literatures. This is an 18-year-old patient, housewife, from Bamako, admitted in the Infectious and tropical diseases department of the University teaching hospital Point G of Bamako on March 13, 2022 for fever and impaired consciousness. Her symptomatology appears to have gradually set in over a month, preceded by headache resistant to paracetamol, jet vomiting and irregular dry cough, initially treated with ceftriaxone, artesunate and paracetamol for confirmed malaria and suspicion of bacterial meningitis before admission. In whom no known medical-surgical history, no use of topical corticosteroids, no immunosuppressive therapy, no alcohol or tobacco, and no immunosuppressive pathology was found. The diagnoses of neuromeningeal cryptococcosis, pulmonary tuberculosis and undernutrition were retained in view of clinical and microbiological arguments. Diabetes, sickle cell disease, viral hepatitis B and C, kidney failure and cancer, which are immunosuppressive pathologies, were not found. She was successfully treated with first-line oral antituberculous drugs and fluconazole infusion. Three interests are drawn from this clinical case: neuromeningeal cryptococcosis is not only the prerogative of HIV-positive subjects, a high CD4 count does not always mean immunocompetence and fluconazole is an effective therapeutic alternative for neuromeningeal cryptococcosis.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940277/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10765183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Anopheles gambiae s.l. larval habitats and resistance mechanisms in Kribi, Cameroon]. [喀麦隆克里比地区冈比亚按蚊幼虫栖息地和抗性机制]。
Pub Date : 2022-12-31 DOI: 10.48327/mtsi.v2i4.2022.284
Patrick Ntonga Akono, Roméo Serge Mbongue, Gisèle Aurélie Foko Dadji, Henri Gabriel Tsila, Léger Offono Enama, Francis Nopowo Takap, Wolfgang Eyisap Ekoko, Jean Arthur Mbida Mbida

Background: The effectiveness of Long-Lasting Insecticidal Nets (LLINs) and indoor residual spraying (IRS) in controlling malaria vectors is hampered by the resistance of anopheles to insecticides. A good knowledge of the breeding sites and of the resistance profile of the vectors could facilitate the development of an appropriate control strategy. This study looks at the larval ecology and the susceptibility profile of An. gambiae s.l. to insecticides in urban and rural areas in Kribi, South Region of Cameroon.

Methods: Mosquito breeding sites were categorized and geo-referenced. For each site, larvae were collected and reared and physicochemical parameters were measured in situ. The susceptibility of anopheles to dichlorodiphenyltrichloroethane (DDT), deltamethrin and permethrin, after pre-exposure to piperonyl butoxide (PBO) or not, was evaluated on the reared larvae. The Kdr mutation was detected using the Hot Oligonucleotide Ligation Assay (HOLA).

Results: Natural breeding sites of An. gambiae s.l. were tyre tracks (12%, n=10), unbuilt wells (5%, n=4), pools of residual water (57%, n=48), foot and hoof prints, gullies, streams and the banks of the Kienké River (15%, n=13). Artificial breeding sites were abandoned dugouts (11%, n=9). Breeding sites in urban areas were characterized by higher mean values of temperature, conductivity, salinity and turbidity compared to the breeding sites in the rural area. The breeding sites of An. gambiae s.l. in urban Kribi were found to be sunnier than those in rural Kribi. A total of 4320 adults were used for testing, 1 440 mosquitoes from rural Kribi, 1 440 from urban Kribi and 1 440 specimens from the laboratory Kisumu strain. For DDT and deltamethrin, susceptibility tests showed that mortality was lower in a situation of no pre-exposure to PBO than in a situation of pre-exposure to PBO in the two study areas. The frequency of the resistant allele (R) was high for the Kdr West mutation in both urban (0.94) and rural areas in Kribi (0.93).

Conclusion: An. gambiae s.l. colonizes a wide range of breeding sites and develops metabolic and mutation resistance to recommended insecticides. The search of alternative molecules for vector control is a necessity.

背景:长效杀虫蚊帐(LLINs)和室内滞留喷洒(IRS)在控制疟疾病媒方面的效果受到按蚊对杀虫剂抗性的影响。对孳生地点和病媒抗性概况的充分了解有助于制定适当的控制策略。本研究探讨了安虫的幼虫生态和易感特征。在喀麦隆南部地区克里比的城市和农村地区,冈比亚线虫对杀虫剂的抗性。方法:对蚊虫孳生地进行分类和地理参考。对每个地点采集和饲养幼虫,就地测定理化参数。以饲养的按蚊为研究对象,研究了预暴露于或未暴露于胡椒酰丁二醇(PBO)后,按蚊对DDT、溴氰菊酯和氯菊酯的敏感性。使用热寡核苷酸结扎法(HOLA)检测Kdr突变。结果:黄麻属天然孳生地。gambiae s.l.是轮胎痕迹(12%,n=10),未建井(5%,n=4),残水池(57%,n=48),脚和蹄印,沟渠,溪流和kienk河岸(15%,n=13)。人工养殖场所为废弃的防空洞(11%,n=9)。城市养殖场的温度、电导率、盐度和浊度平均值均高于农村养殖场。安的繁殖地。克里比城市地区的冈比亚人比农村地区的冈比亚人阳光更充足。共利用4320只成人蚊虫进行检测,其中克里比农村蚊虫1440只,克里比城市蚊虫1440只,实验室基苏木菌株1440只。对于滴滴涕和溴氰菊酯,药敏试验表明,在两个研究地区,未预先接触PBO的情况下,死亡率低于预先接触PBO的情况。krdr西部突变的抗性等位基因(R)在城市(0.94)和农村(0.93)均较高。结论:一个。冈比亚虫在广泛的繁殖地点定居,并对推荐的杀虫剂产生代谢和突变抗性。寻找替代分子来控制病媒是必要的。
{"title":"[<i>Anopheles gambiae</i> s.l. larval habitats and resistance mechanisms in Kribi, Cameroon].","authors":"Patrick Ntonga Akono,&nbsp;Roméo Serge Mbongue,&nbsp;Gisèle Aurélie Foko Dadji,&nbsp;Henri Gabriel Tsila,&nbsp;Léger Offono Enama,&nbsp;Francis Nopowo Takap,&nbsp;Wolfgang Eyisap Ekoko,&nbsp;Jean Arthur Mbida Mbida","doi":"10.48327/mtsi.v2i4.2022.284","DOIUrl":"https://doi.org/10.48327/mtsi.v2i4.2022.284","url":null,"abstract":"<p><strong>Background: </strong>The effectiveness of Long-Lasting Insecticidal Nets (LLINs) and indoor residual spraying (IRS) in controlling malaria vectors is hampered by the resistance of anopheles to insecticides. A good knowledge of the breeding sites and of the resistance profile of the vectors could facilitate the development of an appropriate control strategy. This study looks at the larval ecology and the susceptibility profile of <i>An. gambiae</i> s.l. to insecticides in urban and rural areas in Kribi, South Region of Cameroon.</p><p><strong>Methods: </strong>Mosquito breeding sites were categorized and geo-referenced. For each site, larvae were collected and reared and physicochemical parameters were measured <i>in situ</i>. The susceptibility of anopheles to dichlorodiphenyltrichloroethane (DDT), deltamethrin and permethrin, after pre-exposure to piperonyl butoxide (PBO) or not, was evaluated on the reared larvae. The <i>Kdr</i> mutation was detected using the Hot Oligonucleotide Ligation Assay (HOLA).</p><p><strong>Results: </strong>Natural breeding sites of <i>An. gambiae</i> s.l. were tyre tracks (12%, n=10), unbuilt wells (5%, n=4), pools of residual water (57%, n=48), foot and hoof prints, gullies, streams and the banks of the Kienké River (15%, n=13). Artificial breeding sites were abandoned dugouts (11%, n=9). Breeding sites in urban areas were characterized by higher mean values of temperature, conductivity, salinity and turbidity compared to the breeding sites in the rural area. The breeding sites of <i>An. gambiae</i> s.l. in urban Kribi were found to be sunnier than those in rural Kribi. A total of 4320 adults were used for testing, 1 440 mosquitoes from rural Kribi, 1 440 from urban Kribi and 1 440 specimens from the laboratory Kisumu strain. For DDT and deltamethrin, susceptibility tests showed that mortality was lower in a situation of no pre-exposure to PBO than in a situation of pre-exposure to PBO in the two study areas. The frequency of the resistant allele (R) was high for the <i>Kdr</i> West mutation in both urban (0.94) and rural areas in Kribi (0.93).</p><p><strong>Conclusion: </strong><i>An. gambiae</i> s.l. colonizes a wide range of breeding sites and develops metabolic and mutation resistance to recommended insecticides. The search of alternative molecules for vector control is a necessity.</p>","PeriodicalId":18493,"journal":{"name":"Medecine tropicale et sante internationale","volume":"2 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940278/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10824079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medecine tropicale et sante internationale
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1